Conference: ACCP Annual Meeting
Date: September 14 - 16, 2025
Location: Phoenix, Arizona
Booth: #4
Where to hear Certara insights and expertise
Presenters: Amy S. Cheung, PhD
MIDD Strategies for Preclinical and Clinical Translation & A Comprehensive Solution Designed to Reduce Reliance on Animal Testing
Presenters: Carrie Malinczak, PhD, Director of Toxicology, Certara | David Wesche, MD, PhD, Vice President, Clinical Pharmacology
Drug development is moving from traditional scaling to advanced modeling that integrates pharmacology, biomarkers, and disease biology. Certara’s framework supports preclinical-to-clinical translation with study design, modeling, and iterative data-driven refinement.
With the FDA encouraging New Approach Methodologies (NAMs) to reduce animal testing, Certara’s Non-Animal Navigator™️ helps sponsors implement NAMs through program analysis, tailored development plans, regulatory support, and AI-enabled modeling tools, accelerating development while minimizing animal use.
In this learning lab, we will present case studies highlighting the applications of model-informed translational techniques and applications of NAMs to reduce and even replace the need for animal studies.
Presenters: Karen Yeo, PhD
Presenters: Piet van der Graaf, PharmD, PhD
Presenters: Amin Rostami, PhD
Request a meeting with our experts
